Ana Graf

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

Clifford R. Jack, J. Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia · 2024 · 2.2K citations · Full text

Medicine, Geriatric Medicine, Neurology +15

Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

Bengt Winblad, Niels Andreasen, Lennart Minthon et al. · The Lancet Neurology · 2012 · 304 citations

Life Sciences, Immunology, Neurology +16

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease

Ulf Neumann, Mike Ufer, Laura H. Jacobson et al. · EMBO Molecular Medicine · 2018 · 172 citations · Full text

Medicine, Neuroscience, Pharmacology +12

Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease

Martin R. Farlow, Niels Andreasen, Marie‐Emmanuelle Riviere et al. · Alzheimer s Research & Therapy · 2015 · 143 citations · Full text

Life Sciences, Immunology, Neurology +17

AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study

Fabrizio Stocchi, Olivier Rascol, A. Destée et al. · Movement Disorders · 2013 · 137 citations

Medicine, Pharmacology, Pharmacotherapy +17